Education
About Us
Working with TipRanks
Follow Us
Michael S. Weiss Insider Profile
53 Followers
Michael S. Weiss, CEO, Director at TG Therapeutics, holds 13.82M shares in TG Therapeutics (Ticker: TGTX), holds 124.81K shares in Checkpoint Therapeutics (Ticker: CKPT), holds 1.35M shares in Fortress Biotech (Ticker: FBIO).
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+43.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael S. Weiss holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael S. Weiss
Michael S. Weiss's Trading History
TG Therapeutics
Jan 30, 2025
CEO, Director
Uninformative Buy
―
$531.43M
Checkpoint Therapeutics
Dec 17, 2024
Director
Uninformative Buy
―
$308.29K
Avenue Therapeutics
Aug 08, 2018
Director
Uninformative Buy
―
$24.17K
Fortress Biotech
Jan 03, 2024
Executive Vice Chairman, Strategic Development, Director, Ten Percent Owner
Uninformative Buy
―
$2.07M
Mustang Bio
Jul 07, 2023
Director
Uninformative Buy
―
$73.46K
Origo Acquisition Corporation
―
―
―
―
Keryx Biopharma
May 12, 2010
―
Informative Sell
304.50K
$4.44M
XTL Biopharmaceuticals Ltd. Sponsored ADR
―
Director
―
$11.59M
List of latest transactions for each holding click on a transaction to see Michael S. Weiss's performance on stock
You May Also Like
Michael S. Weiss insider profile FAQ
What is the percentage of profitable transactions made by Michael S. Weiss?
The percentage of profitable transactions made by Michael S. Weiss is 71%.
What is the average return per transaction made by Michael S. Weiss?
The average return per transaction made by Michael S. Weiss is 43.60%.
What stocks does Michael S. Weiss hold?
Michael S. Weiss holds: TGTX, CKPT, ATXI, FBIO, MBIO, OACQF, KERX, XTLB stocks.
What was Michael S. Weiss’s latest transaction?
Michael S. Weiss latest transaction was an Uninformative Buy of ―.
What was Michael S. Weiss's most profitable transaction?
Michael S. Weiss’s most profitable transaction was an Informative Buy of TGTX stock on June 27, 2019. The return on the trade was 131.40%.
What is Michael S. Weiss's role in TG Therapeutics?
Michael S. Weiss's role in TG Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.